NasdaqCM - BOATS Real Time Price USD

Ridgetech, Inc. (RDGT)

1.5200 +0.1200 (+8.57%)
At close: June 29 at 4:00:00 PM EDT
1.5200 0.0000 (0.00%)
Overnight: 8:21:04 PM EDT
Chart Range Bar
Loading chart for RDGT
Chart does not reflect overnight price.
  • Previous Close 1.4000
  • Open 1.3700
  • Bid 1.1700 x 200
  • Ask 1.7600 x 200
  • Day's Range 1.3700 - 1.6493
  • 52 Week Range 1.2100 - 760.5000
  • Volume 947,229
  • Avg. Volume 2,494,320
  • Market Cap (intraday) 1.366M
  • Beta (5Y Monthly) -0.21
  • PE Ratio (TTM) --
  • EPS (TTM) -54.6100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.

www.ridgetch.com

61

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 6/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RDGT
99.64%
S&P 500 (^GSPC)
8.69%

1-Year Return

RDGT
99.07%
S&P 500 (^GSPC)
20.53%

3-Year Return

RDGT
99.88%
S&P 500 (^GSPC)
69.24%

5-Year Return

RDGT
100.00%
S&P 500 (^GSPC)
73.36%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY11
Revenue 18.04M
Earnings 2.24M

Q1

FY11

Q2

FY11

Q3

FY11

0
5M
10M
15M
 

Statistics

View More

Valuation Measures

Annual
As of 6/26/2026
  • Market Cap

    1.31M

  • Enterprise Value

    -7.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.04

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    66.33

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.35%

  • Return on Assets (ttm)

    -1.23%

  • Return on Equity (ttm)

    -8.02%

  • Revenue (ttm)

    119.94M

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -54.6100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.94M

  • Total Debt/Equity (mrq)

    15.65%

  • Levered Free Cash Flow (ttm)

    6.04M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch